The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Satya Vani Nannapaneni
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Satya Vani Nannapaneni, a member of the promoter group of Natco Pharma, sold 23,000 equity shares in the open market on 16 September 2025. Her holding declined from 4,02,851 shares (0.22% of total equity) to 3,79,851 shares (0.21%). The total equity share capital of Natco Pharma remains 17,91,09,870 shares of Rs. 2 each. The transaction was disclosed under Regulation 29(2) of the SEBI Takeover Regulations and Form C of the Insider Trading Regulations.
This is a very small sale (only 0.01% of equity) by a member of the promoter group, not the main promoter, and is unlikely to have any meaningful impact on the stock price or shareholder sentiment.